Open access
Oct 2026
Distinct activation mechanisms underlie ligand efficacy at a GPCR
A deep mutational pharmacology approach is developed to measure how each residue in the µ-opioid receptor (µOR) shapes responses to 15 opioids, yielding ∼400,000 measurements of variant effects on signaling and expression, including full concentration-response series for three agonists.
Matthew K. Howard, Eve J. Fine, Karthik Srinivasan et al.
· bioRxiv · 1 citation